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ABSTRACT  
The aim of present work was to develop a new, economical & simple analytical method of Teneligliptin & its validation as per International 
Conference on Harmonization (ICH) guideline, which is a new antidiabetic drug that is used to treat Non-Insulin Dependent Diabetis Melitus 
(NIDDM) patients. A sensitive and specific Ultra Violet (UV) Visible method was developed & the analysis was carried out by using Shimazdu 
1800 Spectrophotometer, 0.1(N) NaOH was used as a solvent. The UV- Visible Spectrophotometric estimation was carried out at a λ max of 242 
nm using 1cm thick quartz cell. Validation of the newly developed method was performed as per International Conference on Harmonization 
(ICH) Q2R1 guideline in the following parameters: Calibration curve, Accuracy, Precision etc.  Newly developed method obeys Beer’s-Lambert’s 
law in the concentration range of 5 - 25 μg / ml, whereas correlation coefficient value is less than 1. The percent amount of drug estimated by 
this developed method was 100.91 %, which is very close to 100 %. The validation parameters like Accuracy, Precision, Linearity, Range, Limit 
of detection (LOD) & Limit of Quantification (LOQ) were studied for the developed method and was found to be within the limits. 
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INTRODUCTION: 
Analytical chemistry 1 is an important branch of Chemistry. It 
is employed in separating, identifying and determining the 
relative amounts of the components making up a sample of 
matter. Distillation and precipitation techniques for the 
separation of components of complex mixtures prior to their 
qualitative or quantitative determination were replaced by 
sophisticated Chromatographic techniques 2. Methods for 
separation and determination of chemical species are known 
collectively as instrumental methods of analysis. Most 
important instrumental methods like Spectroscopy, 
electrochemistry and Chromatography are used widely in 
present days 3. 
The absorption spectroscopy is based on the measurement 
of transmittance T or the absorbance A of a sample solution 
filled in the transparent cell having a path-length of l cm. 
Generally absorbance is liner with the concentration c of the 
absorbing analyte, as represented by the following equation; 
A = - log T = kcl 
Where, k is the absortivity of the analyte. The photometric 
methods of analysis are based on the Bouger-Lambert-Beer’s 
law, which establishes the absorbance of a solution is 
directly proportional to the concentration of the analyte. 
electronic excitation is found due to absorption of relatively 
high – energy radiation. 4-6. 
Teneligliptin is an antidiabatic drug. It inhibits human 
dipeptidyl peptidase-4(DPP-4). By inhibiting it prevented 
the degradation of incretins GLP-1, GIP and promoted 
insulin release. The IUPAC name {(2S, 4S)- 4- [4- (3- methyl- 
1phenyl- 1Hpyrazol- 5-yl) piperazin- 1- yl] pyrrolidin- 2- yl} 
(1, 3-thiazolidin-3yl) methanone hemipentahydrobromide 
hydrate 7 - 8. 
 
Figure 1. Shows structure of Teneligliptin 
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Literature review 9-13 for Tenagliptin shows that, there are 
very few methods based on different techniques. However, 
there is no method reported for the detection of 
Teneligliptin alone, in bulk and Pharmaceutical formulation 
by UV – Visible Spectrophotometry. The aim of present work 
was to establish a very simple, sensitive, specific, 
Spectrophotometric method development and its validation 
for the detection of Tenagliptin in bulk drug and 
Pharmaceutical formulation. 
MATERIALS AND METHODS: 
Instrument: 
A Shimadzu-1800 UV-Visible double beam 
Spectrophotometer with 1cm matched quartz cells was used 
for all spectral measurements. Authentic drug sample of 
Teneligliptine was given as a gift sample by Zydus Cadila, 
Ahmedabad. Tablets of Teneligliptin procured from local 
market. 
Methods: 
Solvents used for the determination of Teneligliptine in 
UV Spectrophotometer:  
Uv - Visible Spectrophotometric method which involves the 
determination of Teneligliptine in Pharmaceutical 
formulation and has an absorption maximum at 244 nm in 
0.1 N NaOH. It obeys beer’s law in concentration range 5 - 25 
µg/ml.  
Solvent selection: 
In order to select suitable solvent for determination of 
Teneligliptine, various solvents were selected for the 
solubility studies and it was found that Teneligliptine was 
freely soluble in the following solvents: water, ethanol, 
methanol, 0.1N NaOH, Acetonitrile, DMSO (Di Methyl Sulfa 
Oxide) etc. In the present investigation 0.1 (N) NaOH was 
used for initial dilution and all the remaining dilutions also 
carried out by Water only. 
Preparation of standard stock solution:  
It was prepared by dissolving accurately weighed 50 mg of 
Teneligliptine in 50 ml of 0.1N NaOH in 50 ml volumetric 
flask (stock solution-1, 1000 µg/ml). 1ml of stock solution-1 
was diluted to 10 ml with Water (stock solution-2, 100 
µg/ml), then 1ml of stock solution-2 was diluted to 10 ml 
with Water (stock solution-3, 10 µg/ml). Then absorbance of 
resulting solution was measured against respective blank 
solution in the UV region of 200-400 nm, which shows 
maximum absorbance at 242 nm. 
Preparation of standard curve:  
Aliquots of standard solution - 2 of Teneligliptine ranging 
from 0.5 ml – 2.5 ml were transferred into a series of 10 ml 
volumetric flasks separately to prepare concentration ranges 
from 5 µg/ml to 25 µg/ml. The volume in each flask was 
made up to 10 ml with water and the absorbance were 
measured at 242 nm against solvent blank and the 
absorbance values. The obtained absorbance values are 
plotted against the concentration of Teneligliptine to get the 
calibration graph. The concentration of the unknown sample 
was determined from the calibration graph. The correlation 
coefficient was determined. 
 
Figure 2. Shows UV Spectrum of Teneligliptin 
Sample preparation of Teneligliptin:  
Taken 10 tablets, powdered and weighed accurately 
equivalent to 50 mg of Teneligliptin was taken to a 50 ml 
cleaned and dried volumetric flask. This was then diluted 
with 0.1 N NaOH solution upto 50 ml. Then taken 1ml of 
sample solution and dilute with Water, volume was made up 
to 10 ml (100 µg/ml ). This was marked and labeled as Stock 
solution.  Further, an amount of 1ml was pipetted out from 
the above stock solution into a 10 ml volumetric flask and 
diluted up to the mark with diluent to get 10 µg/ml. 
Method validation: 
Various methods for analysis of Tenagliptin in bulk and 
Pharmaceutical formulation were carried out. Then the 
developed method was validated in the following 
parameters as ICH Q2B guideline  
Accuracy: 
Accuracy is the closeness if the test results obtained by the 
method to the true value. To study the accuracy, 10 tablets of 
Teneligliptin were taken, powdered the tablets used to carry 
out the analysis. Recovery studies were carried out by 
addition of standard solution (5, 10, 15 µg/ml) to the sample 
at 3 different concentration levels. 
Precision: 
Accurately weighed amount of 50 mg of Teneligliptin was 
taken to a 50 ml cleaned and dried volumetric flask. This was 
then dissolved with 0.1 N NaOH up to 50 ml. Then 1ml of 
sample solution was taken and dilute with Water, volume 
was made up to 10 ml (100 µg/ml).  Further, an amount of 
1ml was pipetted out from the above stock solution into a 10 
ml volumetric flask and diluted up to the mark with diluent 
to get 10 µg/ml. Then 6 replicates of 10 µg/ml solutions was 
prepared in the same manner. 
Linearity: 
Five point Linearity curve was generated with the 
appropriate volumes of the working standard solutions for 
UV methods. 
Limit of Detection: 
The Limit of detection is the lowest concentration of the 
analyte in a sample that can be detected but not necessarily 
determined in a quantitative fashion using a specific method 
under the required experimental conditions. Such a limit is 
expressed in terms of a concentration of analyte (example:- 
µg / lit ) in the sample. 
LOD = 3.3 SD / S where, SD – is the Standard Deviation, ‘S’ - 
is the slope of the calibration curve for analyte. 
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Limit of Quantification:  
The LOQ is the lowest concentration of analyte in a sample 
that may be measured with an acceptable level of accuracy 
and precision under the above mentioned conditions of the 
method. LOQ value varies with the method used & the 
nature of sample.  
LOQ = 10 SD / S, where, SD – is the Standard Deviation, ‘S’ - 
is the slope of the calibration curve for analyte. 
RESULTS AND DISCUSSION: 
The development of a simple, rapid, sensitive and accurate 
analytical method for the routine quantitative determination 
of samples will reduce unnecessary tedious sample 
reparations and the cost of materials and labour. Specific 
chromophore present in the structure of Tenapliptin 
molecule, absorb at a particular wavelength of UV region and 
this fact was successfully employed for their quantitative 
determinations using the UV – Visible Spectrophotometric 
method. The absorption maxima (λmax) of the drug was 
determined by taking scans of the drug sample solutions in 
the entire UV region. It was found to be that only one peak 
was observed in this method at the wavelength of 242 nm ( 
λmax). 
Accuracy:
                      
Table 1: Accuracy Data of Teneligliptin 
%CONC  Absorbance  CONC. 
(µg/ml)  
%Purity  %Recovery  %Mean  
Standard solution  Sample solution  
50%  0.093  0.099  5  106.7    
50%  0.090  0.097  5  107.8  106.63   
50%  0.091  0.096  5  105.4    
100%  0.290  0.285  10  98.2   101.91  
100%  0.270  0.265  10  98.1  98.3   
100%  0.287  0.283  10  98.6    
150%  0.326  0.330  15  101.2    
150%  0.332  0.328  15  98.8  100.8   
150%  0.329  0.337  15  102.4    
 
Acceptance Criteria:  
The % Recovery should be between 98.0 to 102.0% in each 
level. 
The results obtained for recovery are within the limits. 
So, it is observed from the above table that, accuracy of the 
newly developed method is 101.91%, which is mentioned in 
table 1. Hence the method is accurate. 
Precision: 
Table 2: Precision Data of Teneligliptin 
Concentration (µg/ml) Absorbance 
10 0.240 
10 0.245 
10 0.245 
10 0.247 
10 0.248 
10 0.246 
Mean 0.245 
S.D 0.00279 
% RSD 1.13 
 
Acceptance criteria: 
% RSD of different analytes should not be more than 2. The 
% RSD value of the newly developed method is 1.13, as 
mentioned in Table 2. Which is within the limit, hence the 
method is precise. 
Linearity & Range: 
Table No 3: Linearity Table of Teneligliptin 
Concentration(µg / ml) Absorbance 
5 0.134 
10 0.240 
15 0.342 
20 0.444 
25 0.547 
                              
 
Figure 3. Linearity Graph of Teneligliptin 
Acceptance criteria: 
Correlation coefficient (R2) should not be less than 0.999 
The correlation coefficient obtained was 0.996 in the newly 
developed method, as per Table 3. which is very near to 
acceptance limit. The linearity was established in the range 
of 5% to 25% for Teneligliptin, which is mentioned in Fig. 3. 
LOD & LOQ: 
The LOD & LOQ were calculated as per the formulas, 
mentioned above & was reported as follows.  
Table No 4: LOD & LOQ Table 
Sample LOD (µg/ml) LOQ (µg/ml) 
Teneligliptin 0.42 1.42  
 
 
 
 
y = 0.0195x + 0.0432 
R² = 0.9967 
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CONCLUSION: 
A simple, economic, accurate and precise UV - Vis 
Spectrophotometric method was successfully developed. The 
method developed was statistically validated in terms of 
Accuracy, Linearity, Precision, LOD, LOQ.  Statistical result of 
all the validation parameter was within the prescribed limits. 
Solvent is very economic& very easy to prepare. Hence, the 
UV Spectrophotometric method developed for Teneligliptin 
in Tablet dosages form was found to be economic, rapid, 
simple, sensitive, precise, and accurate.  
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